The American Society of Clinical Oncology (ASCO) recently opened two nasopharyngeal carcinoma guideline drafts for public comment. Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage IB to III Nasopharyngeal Carcinoma, along with Treatment of Recent and/or Metastatic Nasopharyngeal Carcinoma, are the guidelines that are now available for interested parties to comment on. Both guidelines require agreeing to a confidentiality agreement before the guidelines are viewable. Anonymous comments are not accepted.
Click here to view the two nasopharyngeal carcinoma ASCO guidelines currently open for public comment.
Both public comment windows conclude on April 24, 2026 at midnight.
Sign up for alerts to keep up with the latest clinical guidelines and guideline updates.